4.4 Article

Overview of the 2022 WHO Classification of Pituitary Tumors

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medical Laboratory Technology

The Role of T-box Transcription Factor in a Pituitary Adenoma Diagnostic Algorithm

William C. McDonald et al.

Summary: The study successfully classified pituitary adenomas using immunohistochemical stain for Tpit, demonstrating improved sensitivity and specificity compared to previous methods. The results highlight the importance of Tpit staining in adenoma classification, leading to fewer false-negatives and false-positives in diagnosis.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2021)

Article Endocrinology & Metabolism

Immunohistochemistry or Molecular Analysis: Which Method Is Better for Subtyping Craniopharyngioma?

Noriaki Fukuhara et al.

Summary: This study investigated whether immunohistochemistry could replace genetic analysis as an aid in determining the subtype diagnosis of craniopharyngioma. Results showed that immunohistochemistry can assist in distinguishing between adamantinomatous and papillary subtypes, reflecting significant differences in clinical features.

ENDOCRINE PATHOLOGY (2021)

Article Pathology

Cytokeratin profiles in pituitary neuroendocrine tumors

Sylvia L. Asa et al.

Summary: The presence and patterns of keratins play a critical role in the classification of pituitary neuroendocrine tumors. CAM 5.2 and CK18 are the most valuable markers, with almost identical staining patterns observed.

HUMAN PATHOLOGY (2021)

Article Clinical Neurology

Genetic and epigenetic characterization of posterior pituitary tumors

Simone Schmid et al.

Summary: Pituicytoma, granular cell tumor, and spindle cell oncocytoma are rare tumors of the posterior pituitary. Molecular analysis revealed subtle DNA methylation differences but distinct mutation patterns and clinical outcomes, suggesting a combined histo-molecular subclassification into three subtypes based on histology, genetic alterations, and favorable outcomes. The study highlights the potential for targeted therapies based on recurrent genetic alterations in these tumors.

ACTA NEUROPATHOLOGICA (2021)

Article Endocrinology & Metabolism

Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?

Sylvia L. Asa et al.

Summary: Molecular pathology has advanced our understanding of tumors, particularly in pituitary and craniopharyngioma where genetic mutations have been identified. However, these mutations have limited impact on treatment strategies. Epigenetic changes play a crucial role in the pathogenesis of sporadic pituitary neoplasms.

ENDOCRINE PATHOLOGY (2021)

Article Endocrinology & Metabolism

Clinical Outcomes and Complications of Pituitary Blastoma

Anthony P. Y. Liu et al.

Summary: Pituitary blastoma is a rare tumor in infancy with a high mortality rate. Surgical resection is the main treatment, with long-term neuroendocrine management being crucial for quality survival. DICER1 abnormalities are commonly associated with this tumor.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)

Article Endocrinology & Metabolism

Challenges in the Diagnosis of Pituitary Neuroendocrine Tumors

Sylvia L. Asa

Summary: Detailed analysis of PitNETs has led to a formal classification system that reflects the lineage differentiation of non-tumor pituitary cells, and these tumors are now called PitNETs rather than adenomas. It is suggested to relinquish the term "pituitary carcinoma" for metastatic PitNETs that remain well differentiated, and to change the terminology used for tumors that are not terminally differentiated.

ENDOCRINE PATHOLOGY (2021)

Article Endocrinology & Metabolism

Significance of Crooke's Hyaline Change in Nontumorous Corticotrophs of Patients With Cushing Disease

Amit Akirov et al.

Summary: This study found that Crooke's hyaline change (CC) of nontumorous corticotrophs was observed in 83% of patients with Cushing disease (CD), with most patients experiencing remission. Absence of CC in nontumorous corticotrophs may serve as a predictor of reduced remission in patients with CD.

FRONTIERS IN ENDOCRINOLOGY (2021)

Review Pathology

Pituitary neuroendocrine tumors: a model for neuroendocrine tumor classification

Sylvia L. Asa et al.

Summary: The classification of adenohypophysial neoplasms as pituitary neuroendocrine tumors (PitNETs) reflects their characteristics as epithelial neuroendocrine neoplasms with a spectrum of clinical behaviors. Tumor growth and hormone hypersecretion can cause significant morbidity and mortality in patients. The intense study of PitNETs has provided important information about the importance of cellular differentiation in tumor prognosis.

MODERN PATHOLOGY (2021)

Article Endocrinology & Metabolism

Clinical, Biological, Radiological Pathological and Immediate Post-Operative Remission of Sparsely and Densely Granulated Corticotroph Pituitary Tumors: A Retrospective Study of a Cohort of 277 Patients With Cushing's Disease

Beata Rak et al.

Summary: The study found that densely granulated corticotroph adenomas occurred at a younger age, were more commonly microadenomas compared to sparsely granulated tumors, less frequently had invasive features, and more commonly achieved immediate postsurgical hormonal remission. This highlights the importance of accurately differentiating between densely granulated and sparsely granulated subtypes in the pathomorphological diagnosis of corticotropic tumors, especially in invasive PitNETs.

FRONTIERS IN ENDOCRINOLOGY (2021)

Review Medicine, General & Internal

An Update on Pituitary Neuroendocrine Tumors Leading to Acromegaly and Gigantism

Sylvia L. Asa et al.

Summary: Excess growth hormone causes gigantism and acromegaly, which are characterized by accelerated growth and overgrowth of soft tissue and bone. Pituitary neuroendocrine tumors (PitNETs) that produce GH are primarily derived from PIT1-lineage cells, with various pathologic features. These tumors may vary in hormone production and lineage differentiation, resulting in GH excess.

JOURNAL OF CLINICAL MEDICINE (2021)

Review Endocrinology & Metabolism

Progress in the Pathogenesis, Diagnosis, and Treatment of TSH-Secreting Pituitary Neuroendocrine Tumor

Peiqiong Luo et al.

FRONTIERS IN ENDOCRINOLOGY (2020)

Article Pathology

Hypothalamic Vasopressin-Producing Tumors Often Inappropriate Diuresis But Occasionally Cushing Disease

Sylvia L. Asa et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2019)

Review Medicine, General & Internal

Hypothalamic Endocrine Tumors: An Update

Sylvia L. Asa et al.

JOURNAL OF CLINICAL MEDICINE (2019)

Article Pathology

Epidemiology and biomarker profile of pituitary adenohypophysial tumors

Ozgur Mete et al.

MODERN PATHOLOGY (2018)

Article Endocrinology & Metabolism

Synchronous Multiple Pituitary Neuroendocrine Tumors of Different Cell Lineages

Ozgur Mete et al.

ENDOCRINE PATHOLOGY (2018)

Article Oncology

Pituitary acromegaly: not one disease

Sylvia L. Asa et al.

ENDOCRINE-RELATED CANCER (2017)

Article Medical Laboratory Technology

Steroidogenic Factor 1, Pit-1, and Adrenocorticotropic Hormone A Rational Starting Place for the Immunohistochemical Characterization of Pituitary Adenoma

William C. McDonald et al.

ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2017)

Article Oncology

Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy

Priscilla K. Brastianos et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)

Article Oncology

Dramatic Response of BRAF V600E Mutant Papillary Craniopharyngioma to Targeted Therapy

Priscilla K. Brastianos et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)

Review Clinical Neurology

Gangliocytomas of the sellar region: A challenging diagnosis

Giulia Cossu et al.

CLINICAL NEUROLOGY AND NEUROSURGERY (2016)

Article Clinical Neurology

Functional Gonadotroph Adenomas: Case Series and Report of Literature

David J. Cote et al.

NEUROSURGERY (2016)

Review Endocrinology & Metabolism

Aggressive Pituitary Tumors or Localized Pituitary Carcinomas: Defining Pituitary Tumors

Sylvia L. Asa et al.

EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM (2016)

Article Clinical Neurology

Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations

Leanne de Kock et al.

ACTA NEUROPATHOLOGICA (2014)

Review Endocrinology & Metabolism

Functioning Gonadotroph Adenomas

Georgia Ntali et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)

Article Pathology

Spindle Cell Oncocytomas and Granular Cell Tumors of the Pituitary Are Variants of Pituicytoma

Ozgur Mete et al.

AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2013)

Article Clinical Neurology

Clinicopathological analysis of nonfunctioning pituitary adenomas in patients younger than 25 years of age Clinical article

Mitsuo Yamaguchi-Okada et al.

JOURNAL OF NEUROSURGERY-PEDIATRICS (2012)

Article Endocrinology & Metabolism

Pituitary blastoma: a unique embryonal tumor

Bernd W. Scheithauer et al.

PITUITARY (2012)

Article Endocrinology & Metabolism

Gangliocytomas of the sellar region — a review

M. J. A. Puchner et al.

EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2009)

Article Pathology

Medullary thyroid carcinoma metastatic to the pituitary gland: an unusual site of metastasis

Michelle D. Williams et al.

ANNALS OF DIAGNOSTIC PATHOLOGY (2008)

Review Cell Biology

Pathology of the human pituitary adenomas

Robert Y. Osamura et al.

HISTOCHEMISTRY AND CELL BIOLOGY (2008)

Article Pathology

Transdifferentiation of somatotrophs to thyrotrophs in the pituitary of patients with protracted primary hypothyroidism

S Vidal et al.

VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY (2000)